NEI Audacious Goals Initiative in Vision Research High Priority Research Area: Molecular Therapies for Eye Disease (R01)

Post Date

July 24th 2013

Application Due Date

September 7th 2016

Funding Opportunity Number

PA-13-283

CFDA Number(s)

93.867

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Funding

• Award Range:

  $None - $None

Grant Description

The NEI Audacious Goals Initiative identified as a high priority research area the development of new treatments for eye disease using molecular approaches. The purpose of this Funding Opportunity Announcement is to encourage submission of new, innovative projects directed to exploring this area by developing treatments through: 1) the control, modification, and delivery of genetic information; or 2) through the development of small molecules and optogenetic approaches to treat eye disease and to restore sight. Applications may address treatment of disease in any portion of the visual system. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research. It is appropriate to propose small, multidisciplinary teams applying an integrative approach to solve these problems.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PA-13-283.html